XNASMASS
Market cap103mUSD
Jan 17, Last price
2.98USD
1D
2.76%
1Q
-16.99%
IPO
-94.10%
Name
908 Devices Inc.
Chart & Performance
P/E
—
P/S
2.07
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
11.17%
Rev. gr., 5y
17.89%
Revenues
50m
+7.21%
Net income
-36m
L+14.66%
CFO
-25m
L+19.73%
Earnings
Mar 03, 2025
Profile
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | ||||||
Revenues | 50,229 7.21% | 46,852 11.01% | ||||
Cost of revenue | 46,811 | 38,355 | ||||
Unusual Expense (Income) | ||||||
NOPBT | 3,418 | 8,497 | ||||
NOPBT Margin | 6.80% | 18.14% | ||||
Operating Taxes | (211) | (1,819) | ||||
Tax Rate | ||||||
NOPAT | 3,629 | 10,316 | ||||
Net income | (36,399) 14.66% | (31,744) 43.53% | ||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | 936 | 1,291 | ||||
BB yield | -0.26% | -0.54% | ||||
| Debt | ||||||
Debt current | 4,032 | 1,468 | ||||
Long-term debt | 13,803 | 16,468 | ||||
Deferred revenue | 8,571 | 11,496 | ||||
Other long-term liabilities | (7,858) | 3,595 | ||||
Net debt | (127,847) | (170,486) | ||||
| Cash flow | ||||||
Cash from operating activities | (25,059) | (20,930) | ||||
CAPEX | (2,045) | (2,045) | ||||
Cash from investing activities | (26,400) | (15,807) | ||||
Cash from financing activities | (15,935) | 1,179 | ||||
FCF | 948 | 15,944 | ||||
| Balance | ||||||
Cash | 145,682 | 188,422 | ||||
Long term investments | ||||||
Excess cash | 143,171 | 186,079 | ||||
Stockholders' equity | (169,201) | (133,370) | ||||
Invested Capital | 351,224 | 355,528 | ||||
ROIC | 1.03% | 3.00% | ||||
ROCE | 1.85% | 3.78% | ||||
| EV | ||||||
Common stock shares outstanding | 32,239 | 31,493 | ||||
Price | 11.22 47.24% | 7.62 -70.55% | ||||
Market cap | 361,726 50.74% | 239,973 -66.82% | ||||
EV | 233,879 | 69,487 | ||||
EBITDA | 5,802 | 10,111 | ||||
EV/EBITDA | 40.31 | 6.87 | ||||
Interest | 201 | 129 | ||||
Interest/NOPBT | 5.88% | 1.52% | ||||